{"url":"https://newsforagent.com/news/2026-10-15/reveleer-jean-luc-neptune-chief-medical-officer","markdown_url":"https://newsforagent.com/news/2026-10-15/reveleer-jean-luc-neptune-chief-medical-officer.md","title":"Reveleer Names Dr. Jean-Luc Neptune Chief Medical Officer","headline":"Reveleer Appoints Dr. Jean-Luc Neptune as Chief Medical Officer to Lead Clinical Strategy","description":"Reveleer appointed Dr. Jean-Luc Neptune as Chief Medical Officer to lead clinical strategy across risk adjustment and quality programs serving 12 million covered lives.","section":"Leadership","published_at":"2026-10-15T20:21:28+00:00","modified_at":"2026-10-15T20:21:28+00:00","author":"News Desk","key_takeaways":["Reveleer appointed Dr. Jean-Luc Neptune as Chief Medical Officer, leading clinical strategy across risk adjustment, quality, and member management programs serving 12 million covered lives.","Dr. Neptune spent more than 20 years as a physician and digital health founder, most recently serving as Clinical Commercial Leader at Commure.","Reveleer has processed more than 2 billion pages of medical records for risk adjustment and quality programs."],"companies":[{"name":"Reveleer","is_primary":true,"profile_url":"https://akta.pro/company-profiles/000053o/reveleer","website":"https://www.reveleer.com"}],"source":{"publisher":"PR Newswire","title":"Reveleer Names Digital Health Innovator Dr. Jean-Luc Neptune Chief Medical Officer","url":"https://www.prnewswire.com/news-releases/reveleer-names-digital-health-innovator-dr-jean-luc-neptune-chief-medical-officer-302910575.html"},"other_sources":[],"tags":["Leadership","Reveleer"],"body_markdown":"[Reveleer](https://akta.pro/company-profiles/000053o/reveleer) appointed Dr. Jean-Luc Neptune as Chief Medical Officer, the company said on October 15, 2026. He will lead clinical strategy across risk adjustment, quality, and member management programs serving 12 million covered lives. Dr. Neptune previously served as Clinical Commercial Leader at Commure, where he helped bring care automation and AI to clinicians and health systems.\n\n## Dr. Neptune's Role and Clinical Strategy\n\nReveleer announced the appointment in a [PR Newswire](https://www.prnewswire.com/news-releases/reveleer-names-digital-health-innovator-dr-jean-luc-neptune-chief-medical-officer-302910575.html) release. Dr. Neptune will help set clinical direction for Reveleer products and bring a clinical voice to the company's strategy across AI, value-based care, and health care payment reform, the company said.\n\nDr. Neptune has spent more than 20 years bringing new technology to clinicians at the point of care, first as a physician and later as a digital health founder. He completed his medical training at Columbia University/NewYork-Presbyterian, is board-certified in internal medicine, and earned an MBA from the Wharton School. Throughout his career, he has founded startups, invested in dozens of companies, practiced as a direct care physician, and operated a physical clinic.\n\n\"Clinical judgement has to shape our AI long before any suggestion reaches a reviewer,\" said Jay Ackerman, CEO of Reveleer. \"As risk adjustment and quality work move from chart review after the visit to the point of care, our AI puts a suggestion in front of a physician while the patient is still in the room.\"\n\nDr. Neptune said clinicians trust AI when it shows its work. \"The industry has adopted AI,\" he said. \"Now every health plan and provider must decide which decisions belong to a clinician.\"\n\nReveleer has processed more than 2 billion pages of medical records for risk adjustment and quality programs. The company's EVE AI links each suggestion to the exact page in the medical record where the evidence appears, allowing coders and clinicians to verify it before making the final call.\n\n## Reveleer's Product and Funding Record\n\nAccording to [akta.pro company records](https://akta.pro/company-data), Reveleer launched EVE Hybrid AI in January 2026, a next-generation AI engine for Prospective Risk Adjustment built on Google Cloud that processes up to 2.1 million clinical charts per day. In October 2025, the company launched an all-in-one RADV Audit SaaS Solution for Medicare Advantage plans.\n\nReveleer acquired Novillus in April 2025, expanding AI-powered clinical intelligence and quality capabilities. The combined entity serves 72 million covered lives across 86 healthcare organizations, the same records show. Reveleer has 10 funding rounds on record, including a $65 million debt-funded round in February 2024 led by Hercules Capital.\n\n## Fireside Chat Scheduled for November 10\n\nDr. Neptune and Ackerman will continue the conversation in a live fireside chat, Keeping Clinical Judgment at the Center of AI in Value-Based Care, on November 10, 2026. The 45-minute session covers Dr. Neptune's path from clinical medicine into health care operations and investing, the conditions AI needs to work inside a clinical workflow, and the decisions that call for clinician or coder review. The session closes with audience questions.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}